| Predicting new molecular targets for known drugs MJ Keiser, V Setola, JJ Irwin, C Laggner, AI Abbas, SJ Hufeisen, ... Nature 462 (7270), 175-181, 2009 | 1871 | 2009 |
| Automated design of ligands to polypharmacological profiles J Besnard, GF Ruda, V Setola, K Abecassis, RM Rodriguiz, XP Huang, ... Nature 492 (7428), 215-220, 2012 | 859 | 2012 |
| Discovery of a novel member of the histamine receptor family T Nguyen, DA Shapiro, SR George, V Setola, DK Lee, R Cheng, L Rauser, ... Molecular pharmacology 59 (3), 427-433, 2001 | 492 | 2001 |
| Discovery of β-arrestin–biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy JA Allen, JM Yost, V Setola, X Chen, MF Sassano, M Chen, S Peterson, ... Proceedings of the National Academy of Sciences 108 (45), 18488-18493, 2011 | 382 | 2011 |
| 3, 4-methylenedioxymethamphetamine (MDMA,“Ecstasy”) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro V Setola, SJ Hufeisen, KJ Grande-Allen, I Vesely, RA Glennon, B Blough, ... Molecular pharmacology 63 (6), 1223-1229, 2003 | 369 | 2003 |
| Ligand discovery from a dopamine D3 receptor homology model and crystal structure J Carlsson, RG Coleman, V Setola, JJ Irwin, H Fan, A Schlessinger, A Sali, ... Nature chemical biology 7 (11), 769-778, 2011 | 353 | 2011 |
| Serotonin receptors and heart valve disease—it was meant 2B JD Hutcheson, V Setola, BL Roth, WD Merryman Pharmacology & therapeutics 132 (2), 146-157, 2011 | 259 | 2011 |
| Identifying mechanism-of-action targets for drugs and probes E Gregori-Puigjané, V Setola, J Hert, BA Crews, JJ Irwin, E Lounkine, ... Proceedings of the National Academy of Sciences 109 (28), 11178-11183, 2012 | 211 | 2012 |
| Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil D Zolkowska, R Jain, RB Rothman, JS Partilla, BL Roth, V Setola, ... Journal of Pharmacology and Experimental Therapeutics 329 (2), 738-746, 2009 | 209 | 2009 |
| Neurochemical profiles of some novel psychoactive substances L Iversen, S Gibbons, R Treble, V Setola, XP Huang, BL Roth European journal of pharmacology 700 (1-3), 147-151, 2013 | 188 | 2013 |
| The ketamine analogue methoxetamine and 3-and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor BL Roth, S Gibbons, W Arunotayanun, XP Huang, V Setola, R Treble, ... PloS one 8 (3), e59334, 2013 | 175 | 2013 |
| Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy F Jaffré, P Bonnin, J Callebert, H Debbabi, V Setola, S Doly, L Monassier, ... Circulation research 104 (1), 113-123, 2009 | 168 | 2009 |
| Serotonin 5-HT2B receptors are required for 3, 4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro S Doly, E Valjent, V Setola, J Callebert, D Hervé, JM Launay, L Maroteaux Journal of Neuroscience 28 (11), 2933-2940, 2008 | 156 | 2008 |
| Chemical informatics and target identification in a zebrafish phenotypic screen C Laggner, D Kokel, V Setola, A Tolia, H Lin, JJ Irwin, MJ Keiser, ... Nature chemical biology 8 (2), 144-146, 2012 | 148 | 2012 |
| Structure–Functional Selectivity Relationship Studies of β-Arrestin-Biased Dopamine D2 Receptor Agonists X Chen, MF Sassano, L Zheng, V Setola, M Chen, X Bai, SV Frye, ... Journal of medicinal chemistry 55 (16), 7141-7153, 2012 | 141 | 2012 |
| Deficient serotonin neurotransmission and depression-like serotonin biomarker alterations in tryptophan hydroxylase 2 (Tph2) loss-of-function mice JPR Jacobsen, WB Siesser, BD Sachs, S Peterson, MJ Cools, V Setola, ... Molecular psychiatry 17 (7), 694-704, 2012 | 138 | 2012 |
| Parallel functional activity profiling reveals valvulopathogens are potent 5-hydroxytryptamine2B receptor agonists: implications for drug safety assessment XP Huang, V Setola, PN Yadav, JA Allen, SC Rogan, BJ Hanson, ... Molecular pharmacology 76 (4), 710-722, 2009 | 136 | 2009 |
| Photochemical activation of TRPA1 channels in neurons and animals D Kokel, CYJ Cheung, R Mills, J Coutinho-Budd, L Huang, V Setola, ... Nature chemical biology 9 (4), 257-263, 2013 | 125 | 2013 |
| 5-HT2B antagonism arrests non-canonical TGF-β1-induced valvular myofibroblast differentiation JD Hutcheson, LM Ryzhova, V Setola, WD Merryman Journal of molecular and cellular cardiology 53 (5), 707-714, 2012 | 123 | 2012 |
| Molecular determinants for the interaction of the valvulopathic anorexigen norfenfluramine with the 5-HT2B receptor V Setola, M Dukat, RA Glennon, BL Roth Molecular pharmacology 68 (1), 20-33, 2005 | 93 | 2005 |
XP HuangUniversity of North Carolina在 unc.edu 的电子邮件经过验证
